Loading...

Rapid Micro Biosystems, Inc.

RPID•NASDAQ
Healthcare
Medical - Devices
$2.64
$-0.21(-7.37%)

Rapid Micro Biosystems, Inc. (RPID) Stock Overview

Explore Rapid Micro Biosystems, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 64.9/100

Key Financials

Market Cap116.2M
P/E Ratio-2.72
EPS (TTM)$-1.00
ROE-0.63%
Fundamental Analysis

AI Price Forecasts

1 Week$3.90
1 Month$3.49
3 Months$4.46
1 Year Target$0.35

RPID Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Rapid Micro Biosystems, Inc. (RPID) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 34.46, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.35.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.72 and a market capitalization of 116.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.23%
5-Day Change
-12.50%
1-Month Change
-7.49%
3-Month Change
103.88%
6-Month Change
138.37%
Year-to-Date (YTD) Change
113.61%
1-Year Change
118.75%
3-Year Change
-63.09%
5-Year Change
-90.19%
All-Time (Max) Change
-90.19%

Contact Information

https://www.rapidmicrobio.com
978 349 3200
1001 Pawtucket Boulevard West, Lowell, MA, 01854

Company Facts

163 Employees
IPO DateJul 15, 2021
CountryUS
Actively Trading

Frequently Asked Questions

;